Depression and risk of developing dementia
暂无分享,去创建一个
[1] K. Hashimoto,et al. Critical role of brain-derived neurotrophic factor in mood disorders , 2004, Brain Research Reviews.
[2] R. Maccioni,et al. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. , 2008, Archives of medical research.
[3] J. Groves,et al. Is it time to reassess the BDNF hypothesis of depression? , 2007, Molecular Psychiatry.
[4] Z Walker,et al. Microglial activation and amyloid deposition in mild cognitive impairment , 2009, Neurology.
[5] C. Halldin,et al. A PET study of , 2000, The international journal of neuropsychopharmacology.
[6] Filippo Caraci,et al. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. , 2010, European journal of pharmacology.
[7] M. Marinelli,et al. Age matters , 2009, The European journal of neuroscience.
[8] D. Price,et al. The neuropathology of aminergic nuclei in Alzheimer's disease , 1988, Progress in clinical and biological research.
[9] A. Zonderman,et al. Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment , 2010, Neurology.
[10] J. Becker,et al. Pathways linking late-life depression to persistent cognitive impairment and dementia , 2008, Dialogues in clinical neuroscience.
[11] Janet B W Williams. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[12] Olga V. Demler,et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.
[13] J. Lindsay,et al. Vascular dementia : incidence and risk factors in the Canadian study of health and aging. , 2000, Stroke.
[14] J. Payne,et al. The Geriatric Mental State Examination in the 21st century , 2002, International journal of geriatric psychiatry.
[15] A. Zonderman,et al. Depressive symptoms, sex, and risk for Alzheimer's disease , 2005, Annals of neurology.
[16] M. Maj,et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression , 2009, Metabolic Brain Disease.
[17] K. Yaffe,et al. Midlife versus late-life depression and risk of dementia: Differential effects for vascular dementia and Alzheimer's disease , 2010, Alzheimer's & Dementia.
[18] A. Hofman,et al. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease , 2008, Neurology.
[19] S. Rubin,et al. Inflammatory markers and cognition in well-functioning African-American and white elders , 2003, Neurology.
[20] R. Rao. Cerebrovascular disease and late life depression: an age old association revisited , 2000, International journal of geriatric psychiatry.
[21] A. Green,et al. Depression and the Risk of Alzheimer Disease , 2005, Epidemiology.
[22] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[23] O. Wolkowitz,et al. Depression gets old fast: do stress and depression accelerate cell aging? , 2010, Depression and anxiety.
[24] R. Kuljiš,et al. The Role of Neuroimmunomodulation in Alzheimer's Disease , 2009, Annals of the New York Academy of Sciences.
[25] L. Flicker. Vascular factors in geriatric psychiatry: time to take a serious look , 2008, Current opinion in psychiatry.
[26] J. Ferro,et al. White matter changes and late-life depressive symptoms , 2007, British Journal of Psychiatry.
[27] M. Takeda,et al. [Vascular depression]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[28] D. Steffens,et al. Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[29] Abraham Weizman,et al. Increased risk for dementia in elderly psychiatric inpatients with late-onset major depression. , 2000, The Journal of nervous and mental disease.
[30] Thomas Hagen,et al. Hippocampal volume reduction and HPA-system activity in major depression. , 2007, Journal of psychiatric research.
[31] M. Murer,et al. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease , 2001, Progress in Neurobiology.
[32] L. Schneider,et al. Sertraline for the treatment of depression in Alzheimer disease. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[33] S. Kanba,et al. Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease. , 2009, Central nervous system agents in medicinal chemistry.
[34] C. Pittenger,et al. Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms , 2008, Neuropsychopharmacology.
[35] C. Baird,et al. The pilot study. , 2000, Orthopedic nursing.
[36] F. Lezoualc’h. 5-HT4 receptor and Alzheimer's disease: The amyloid connection , 2007, Experimental Neurology.
[37] B. McEwen,et al. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. , 1986, Endocrine reviews.
[38] D. Swaab,et al. The stress system in the human brain in depression and neurodegeneration , 2005, Ageing Research Reviews.
[39] M. Webster,et al. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium , 2004, Molecular Psychiatry.
[40] R Brookmeyer,et al. Prevalence of dementia after age 90 , 2008, Neurology.
[42] A. Caspi,et al. Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.
[43] C. Cotman. The Role of Neurotrophins in Brain Aging: A Perspective in Honor of Regino Perez-Polo , 2005, Neurochemical Research.
[44] A. Sierksma,et al. Major depression, cognitive dysfunction and Alzheimer's disease: is there a link? , 2010, European journal of pharmacology.
[45] J. Saczynski,et al. The Honolulu-Asia Aging Study , 2007 .
[46] Louis Valiquette,et al. 10 years later... , 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[47] P. Modrego,et al. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. , 2004, Archives of neurology.
[48] B. Leonard. Inflammation, Depression and Dementia: Are they Connected? , 2007, Neurochemical Research.
[49] K. Yaffe,et al. Dysthymia and depression increase risk of dementia and mortality among older veterans. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[50] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[51] Anil Gholkar,et al. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. , 2004, The American journal of psychiatry.
[52] F. Schmidt. Meta-Analysis , 2008 .
[53] B. Pollock,et al. Persistence of neuropsychologic deficits in the remitted state of late-life depression. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[54] K. Krishnan,et al. Does antidepressant therapy improve cognition in elderly depressed patients? , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.
[55] J. Dartigues,et al. Exploring Sex Differences in the Relationship Between Depressive Symptoms and Dementia Incidence: Prospective Results From the PAQUID Study , 2003, Journal of the American Geriatrics Society.
[56] S. Brophy,et al. Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.
[57] Glenda M MacQueen,et al. Course of illness, hippocampal function, and hippocampal volume in major depression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[58] Casey Crump,et al. Cerebrovascular Disease and Evolution of Depressive Symptoms in the Cardiovascular Health Study , 2002, Stroke.
[59] D. Jolley,et al. Cost benefits of a medically supervised day treatment program for patients with Alzheimer's disease and other forms of dementia , 1989 .
[60] P. Buckley. Apolipoprotein E ε4 Allele Genotype and the Effect of Depressive Symptoms on the Risk of Dementia in Men: The Honolulu-Asia Aging Study , 2009 .
[61] Philip B. Ward,et al. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression , 2005, British Journal of Psychiatry.
[62] J. Copeland,et al. A standardized interview for the elderly (GMS): Reliability studies comparing the Dutch language version with the original , 1991 .
[63] Dora Kanellopoulos,et al. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction. , 2010, The American journal of psychiatry.
[64] W. Taylor,et al. The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[65] B. Pollock,et al. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. , 2003, Journal of psychiatric research.
[66] R. Green,et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. , 2003, Archives of neurology.
[67] Allison Druin,et al. Age matters , 2002 .
[68] P. S. St John,et al. Do depressive symptoms predict Alzheimer's disease and dementia? , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[69] A. Hofman,et al. Cerebral white matter lesions and depressive symptoms in elderly adults. , 2000, Archives of general psychiatry.
[70] C. Cotman. PL6.1 Keynote lecture: Exercise builds brain health: key roles of growth factor cascades and inflammation , 2008 .
[71] L. Sifonios,et al. Chronic treatment with high doses of corticosterone decreases cytoskeletal proteins in the rat hippocampus , 2006, The European journal of neuroscience.
[72] Lukas Scheef,et al. No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression , 2009, Psychiatric genetics.
[73] J. Becker,et al. Depressed mood is not a risk factor for incident dementia in a community-based cohort. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[74] A. Caspi,et al. Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.
[75] J. Kim,et al. Stress effects in the hippocampus: Synaptic plasticity and memory , 2006, Stress.
[76] Gérard Waeber,et al. Geriatric depression and vascular diseases: what are the links? , 2004, Journal of affective disorders.
[77] H. Sackeim,et al. Randomized double‐blind placebo‐controlled donepezil augmentation in antidepressant‐treated elderly patients with depression and cognitive impairment: a pilot study , 2008, International journal of geriatric psychiatry.
[78] E. Cankurtaran,et al. Risk factors and type of dementia: vascular or Alzheimer? , 2008, Archives of gerontology and geriatrics.
[79] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[80] A. Versace,et al. P.1.b.002 Anterior cingulate volumes in schizophrenia: a systematic research review and a meta-analysis of MRI studies , 2006, European Neuropsychopharmacology.
[81] Anthony F Jorm. History of Depression as a Risk Factor for Dementia: An Updated Review , 2001, The Australian and New Zealand journal of psychiatry.
[82] G. Alexopoulos,et al. 'Vascular depression' hypothesis. , 1997, Archives of general psychiatry.
[83] Deanna M Barch,et al. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. , 2008, The American journal of psychiatry.
[84] G. Alexopoulos. The Vascular Depression Hypothesis: 10 Years Later , 2006, Biological Psychiatry.
[85] H. Braak,et al. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease , 2009, Acta Neuropathologica.
[86] Lester C. Loschky,et al. What Is the Relationship , 1994 .
[87] H. Manji,et al. Life Stress, Genes, and Depression: Multiple Pathways Lead to Increased Risk and New Opportunities for Intervention , 2004, Science's STKE.
[88] Ruoling Chen,et al. Severity of depression and risk for subsequent dementia: cohort studies in China and the UK , 2008, British Journal of Psychiatry.
[89] M. Folstein,et al. Amyloid-associated depression: a prodromal depression of Alzheimer disease? , 2008, Archives of general psychiatry.
[90] T. Dening,et al. Antidepressants for treating depression in dementia. , 2002, The Cochrane database of systematic reviews.
[91] L. Radloff. The CES-D Scale , 1977 .
[92] Carl W. Cotman,et al. Exercise builds brain health: key roles of growth factor cascades and inflammation , 2007, Trends in Neurosciences.
[93] Yun Hu,et al. Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival , 2007, Experimental Neurology.
[94] J. Copeland,et al. Dementia and depression in elderly persons: Agecat compared with dsm III and pervasive illness , 1990 .
[95] David Loewenstein,et al. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.
[96] L. Launer,et al. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study. , 2008, Archives of general psychiatry.
[97] E. Gudayol-Ferré,et al. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. , 2009, Journal of psychiatric research.
[98] F. Angelucci,et al. BDNF in schizophrenia, depression and corresponding animal models , 2005, Molecular Psychiatry.
[99] Zubenko Gs. Biological correlates of clinical heterogeneity in primary dementia , 1992 .
[100] G. Zubenko. Biological correlates of clinical heterogeneity in primary dementia. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[101] Klaus P. Ebmeier,et al. White matter hyperintensities in late life depression: a systematic review , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[102] Maja O’Connor. LONGITUDINAL STUDY , 2013 .
[103] Eric J. Nestler,et al. The molecular neurobiology of depression , 2008, Nature.
[104] Michael A Rapp,et al. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. , 2006, Archives of general psychiatry.
[105] L. Bouter,et al. Depressive Symptoms and Risk of Alzheimer's Disease in More Highly Educated Older People , 2000, Journal of the American Geriatrics Society.
[106] D. Diamond,et al. Acute predator stress impairs the consolidation and retrieval of hippocampus-dependent memory in male and female rats. , 2008, Learning & memory.
[107] Alan J. Thomas,et al. Depression and vascular disease: what is the relationship? , 2004, Journal of affective disorders.
[108] B. Ravnkilde,et al. Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.
[109] D. Bennett,et al. Depressive symptoms, cognitive decline, and risk of AD in older persons , 2002, Neurology.
[110] Anne Corbett,et al. Depression and dementia. , 2011, Mental health today.
[111] R. Hébert,et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. , 2002, American journal of epidemiology.
[112] V. Preedy,et al. Prospective Cohort Study , 2010 .
[113] Jason Brandt,et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. , 2003, Archives of general psychiatry.
[114] O. Wolkowitz,et al. Glucocorticoids. Mood, memory, and mechanisms. , 2009, Annals of the New York Academy of Sciences.
[115] G. Alexopoulos. Vascular Disease, Depression, and Dementia , 2003, Journal of the American Geriatrics Society.
[116] W. M. van der Flier,et al. Hippocampal atrophy in Alzheimer disease: Age matters , 2006, Neurology.
[117] H. Kraemer,et al. Untreated depression and hippocampal volume loss. , 2003, The American journal of psychiatry.
[118] H. Sackeim,et al. Sertraline treatment of elderly patients with depression and cognitive impairment , 2003, International journal of geriatric psychiatry.
[119] D. Steffens,et al. Geriatric depression and cognitive impairment , 2007, Psychological Medicine.
[120] V. Leirer,et al. Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.
[121] M. Mattson,et al. Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease , 2010, NeuroMolecular Medicine.
[122] Victoria Arango,et al. Volumetric Analysis of the Prefrontal Cortex, Amygdala, and Hippocampus in Major Depression , 2004, Neuropsychopharmacology.
[123] J. Kramer,et al. Mild cognitive impairment, dementia, and their subtypes in oldest old women. , 2011, Archives of neurology.
[124] A. Mowla,et al. Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?: A Double-Blind, Placebo-Controlled, Clinical Trial , 2007, Journal of clinical psychopharmacology.
[125] I. Skoog,et al. Depression as a Risk Factor for the Incidence of First-Ever Stroke in 85-Year-Olds , 2008, Stroke.
[126] Y. Ihara,et al. Alzheimer's disease: β‐Amyloid protein and tau , 2002, Journal of neuroscience research.
[127] M. Webster,et al. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium , 2004, Molecular Psychiatry.
[128] L. Flicker. Cardiovascular risk factors, cerebrovascular disease burden, and healthy brain aging. , 2010, Clinics in geriatric medicine.
[129] R. Levy,et al. Clinical and neuropathological correlates of depression in Alzheimer's disease , 1992, Psychological Medicine.
[130] Shawn F. Sorrells,et al. An inflammatory review of glucocorticoid actions in the CNS , 2007, Brain, Behavior, and Immunity.
[131] R. Barber,et al. Pathologies and Pathological Mechanisms for White Matter Hyperintensities in Depression , 2002, Annals of the New York Academy of Sciences.
[132] C. Ballard,et al. The prevalence, associations and symptoms of depression amongst dementia sufferers. , 1996, Journal of affective disorders.
[133] H. Wagner,et al. Hippocampal volume and incident dementia in geriatric depression. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[134] Kathryn Ziegler-Graham,et al. Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.
[135] G. Aliev,et al. Integrated treatment approach improves cognitive function in demented and clinically depressed patients , 2005, American journal of Alzheimer's disease and other dementias.
[136] K. Krishnan,et al. MRI-defined vascular depression. , 1997, The American journal of psychiatry.
[137] M. Schwald,et al. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. , 2005, Brain research. Molecular brain research.
[138] I. McKeith,et al. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. , 2000, Journal of affective disorders.
[139] F J Durgin,et al. Depression in the elderly. , 1978, Comprehensive therapy.
[140] J. D. McGaugh,et al. Glucocorticoids Increase Amyloid-β and Tau Pathology in a Mouse Model of Alzheimer’s Disease , 2006, The Journal of Neuroscience.
[141] H. Soininen,et al. Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease , 2010, Annals of neurology.
[142] K. Yaffe,et al. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. , 2012, Archives of general psychiatry.
[143] Ki Woong Kim,et al. Depression in Vascular Dementia Is Quantitatively and Qualitatively Different from Depression in Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.
[144] D. Perl,et al. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[145] L. Schneider,et al. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[146] Shijing Huang,et al. Vascular depression , 2010 .